Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33763699

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Jul 1
First author
Facon T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Jul 1;137(26):3584-3586. doi: 10.1182/blood.2021011262.
    note
    Source null
    related pmid
    34196682
    relationship
    Comment in

Authors and identifiers

  1. name
    Facon T
    type
    Author
  2. name
    Venner CP
    type
    Author
  3. name
    Bahlis NJ
    type
    Author
  4. name
    Offner F
    type
    Author
  5. name
    White DJ
    type
    Author
  6. name
    Karlin L
    type
    Author
  7. name
    Benboubker L
    type
    Author
  8. name
    Rigaudeau S
    type
    Author
  9. name
    Rodon P
    type
    Author
  10. name
    Voog E
    type
    Author
  11. name
    Yoon SS
    type
    Author
  12. name
    Suzuki K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Facon T
    type
    Author
  2. name
    Venner CP
    type
    Author
  3. name
    Bahlis NJ
    type
    Author
  4. name
    Offner F
    type
    Author
  5. name
    White DJ
    type
    Author
  6. name
    Karlin L
    type
    Author
  7. name
    Benboubker L
    type
    Author
  8. name
    Rigaudeau S
    type
    Author
  9. name
    Rodon P
    type
    Author
  10. name
    Voog E
    type
    Author
  11. name
    Yoon SS
    type
    Author
  12. name
    Suzuki K
    type
    Author
bibliography ids
  1. nci-bib-4c2f3245f629f40d3f7bc0e7
book metadata
content sha256
0d23baf725f27793511e30c62d3c2e16b9d91115f8775bcec39e63b476b9678e
document type
citation
dois
  1. 10.1182/blood.2020008787
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33763699
immutable id
pubmed:33763699@0d23baf725f27793511e30c62d3c2e16b9d91115f8775bcec39e63b476b9678e
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
26
name
Blood
nlm unique id
7603509
pages
3616-3628
volume
137
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Jul 1;137(26):3584-3586. doi: 10.1182/blood.2021011262.
    note
    Source null
    related pmid
    34196682
    relationship
    Comment in
outcomes validated
false
pmid
33763699
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
e75fe81fba97f5c7f866493783bc27e7e313ac50c10221266e747190b113627a
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jul 1
precision
day
year
2021
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33763699/
title
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma.

Preserved source evidence · Not medical advice